Hongchao Zheng

机构：National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases · ORCID：0000-0003-2205-175X

发表论文 63 篇 · 总被引 932 次 · h-index 17

代表论文

• Assessing inhibitors of mutant isocitrate dehydrogenase using a suite of pre-clinical discovery assays (2017 · Scientific Reports · 被引 68)
• Conformational constraints of cyclopentane peptide nucleic acids facilitate tunable binding to DNA (2020 · Nucleic Acids Research · 被引 31)
• Allosteric modulation of β-cell M 3 muscarinic acetylcholine receptors greatly improves glucose homeostasis in lean and obese mice (2019 · Proceedings of the National Academy of Sciences · 被引 31)
• Discovery and Optimization of 2 H -1λ 2 -Pyridin-2-one Inhibitors of Mutant Isocitrate Dehydrogenase 1 for the Treatment of Cancer (2021 · Journal of Medicinal Chemistry · 被引 29)
• Thyclotides, tetrahydrofuran-modified peptide nucleic acids that efficiently penetrate cells and inhibit microRNA-21 (2022 · Nucleic Acids Research · 被引 21)
• Multistage data center cooling system for temperature gradation and matching (2024 · Applied Energy · 被引 20)